Literature DB >> 2423866

In vitro translation of rat liver and Novikoff hepatoma cytokeratin mRNAs.

W M Krajewska, W N Schmidt, L S Hnilica.   

Abstract

Cytoplasmic poly(A)+ RNA was isolated from normal rat liver and Novikoff ascites hepatoma cells, translated in vitro using rabbit reticulocyte lysate system and the translational products were assayed by immunoprecipitation with antibodies specific for Novikoff hepatoma principal cytokeratins p39, p49 (a group of hepatic cytokeratins C, D, and E) and p56. The identity of the precipitated antigens was further confirmed by two-dimensional polyacrylamide gel electrophoresis. Only the Novikoff hepatoma poly(A)+ RNA contained translatable mRNA coding for the p39 cytokeratin while the p49 and p56 cytokeratins were translated from both the normal rat liver and Novikoff hepatoma poly(A)+ RNAs. Immunoprecipitations employing monoclonal antibody specific for p39 also recovered significant quantities of p56 and 49K cytokeratins, presumably due to oligomeric associations of these proteins with p39 immediately after in vitro synthesis. Similar results were observed after experiments with anti-p56 monoclonal antibody in which p39, not reactive with this antibody, was recovered in immunoprecipitates. Overall, the two-dimensional gel fluorograms of cytokeratins synthesized in vitro from NAH or liver poly(A)+ RNA are quite similar to isolated antigenic and cytokeratin profiles reported previously. These results suggest that overt posttranslational processing is not likely responsible for the diversity of cytokeratins observed in the liver.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423866     DOI: 10.1007/bf00233805

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Cross-linking of Novikoff ascites hepatoma cytokeratin filaments.

Authors:  W S Ward; W N Schmidt; C A Schmidt; L S Hnilica
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

2.  Visualization of a system of filaments 7-10 nm thick in cultured cells of an epithelioid line (Pt K2) by immunofluorescence microscopy.

Authors:  M Osborn; W W Franke; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

5.  Tissue specificity of epithelial keratins: differential expression of mRNAs from two multigene families.

Authors:  K H Kim; J G Rheinwald; E V Fuchs
Journal:  Mol Cell Biol       Date:  1983-04       Impact factor: 4.272

6.  Protein complexes of intermediate-sized filaments: melting of cytokeratin complexes in urea reveals different polypeptide separation characteristics.

Authors:  W W Franke; D L Schiller; M Hatzfeld; S Winter
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Identification of cytokeratin antigens in Novikoff ascites hepatoma.

Authors:  W N Schmidt; R L Pardue; M C Tutt; R C Briggs; B R Brinkley; L S Hnilica
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Distribution of Novikoff ascites hepatoma antigens p39 and p49 in various tumorigenic cell lines.

Authors:  W N Schmidt; L S Hnilica
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

9.  Carcinoma-specific keratin polypeptide patterns in keratinizing epithelia of rodents : independence of species- and tissue-specific variations.

Authors:  H Winter; J Schweizer
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

10.  A subfamily of relatively large and basic cytokeratin polypeptides as defined by peptide mapping is represented by one or several polypeptides in epithelial cells.

Authors:  D L Schiller; W W Franke; B Geiger
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.